Delwedd Flaen

Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study

AbstractContext Yi-Shen-Hua-Shi (YSHS) is a traditional Chinese medicine that treats chronic kidney disease (CKD). However, its efficacy in reducing proteinuria and underlying mechanisms is unknown.Objective This single-center randomized controlled trial explored whether YSHS could improve proteinur...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Xingtong Dong (Awdur), Jialing Zhang (Awdur), Wen Li (Awdur), Yinping Li (Awdur), Linpei Jia (Awdur), Zhaohui Liu (Awdur), Wenjing Fu (Awdur), Aihua Zhang (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Pynciau:	article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes
gan: Mingzhu Liang, et al.
Cyhoeddwyd: (2022)

Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
gan: Zhuojing Tan, et al.
Cyhoeddwyd: (2022)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
gan: Xiuhai Su, et al.
Cyhoeddwyd: (2022)

A brief introduction of Yi Xue Shi (《医学史》 History of Medicine)
gan: Lei Xu
Cyhoeddwyd: (2019)

Distinct Responses of Gut Microbiota to Jian-Pi-Yi-Shen Decoction Are Associated With Improved Clinical Outcomes in 5/6 Nephrectomized Rats
gan: Lin Zheng, et al.
Cyhoeddwyd: (2020)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
gan: Shichao Lv, et al.
Cyhoeddwyd: (2022)

Gu-Ben-Hua-Shi (AESS) formula ameliorates atopic dermatitis via regulating NLRP3 signaling pathways
gan: Xiong Li, et al.
Cyhoeddwyd: (2023)

Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein
gan: Jinjing Jia, et al.
Cyhoeddwyd: (2022)

Yi Shen An, a Chinese traditional prescription, ameliorates membranous glomerulonephritis induced by cationic bovine serum albumin in rats
gan: Yun-Li Zhao, et al.
Cyhoeddwyd: (2022)

Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population
gan: Gabriela Silveira-Nunes, et al.
Cyhoeddwyd: (2020)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
gan: Yule Wang, et al.
Cyhoeddwyd: (2021)

Diagnostic and interactive uses of budgets and the moderating effect of strategic uncertainty / Sabrina Shi Qiong Shen and Sujatha Perera
gan: Shi, Sabrina Qiong Shen, et al.
Cyhoeddwyd: (2012)

He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study
gan: Haibo Hu, et al.
Cyhoeddwyd: (2021)

Periodontitis may induce gut microbiota dysbiosis via salivary microbiota
gan: Jun Bao, et al.
Cyhoeddwyd: (2022)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
gan: Xinhui Liu, et al.
Cyhoeddwyd: (2018)

Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis
gan: Lin Jiang, et al.
Cyhoeddwyd: (2024)

Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition
gan: Yuan Zhao, et al.
Cyhoeddwyd: (2022)

Involvement of Circulating Exosomal MicroRNAs in Jian-Pi-Yi-Shen Formula Protection Against Adenine-Induced Chronic Kidney Disease
gan: Xinhui Liu, et al.
Cyhoeddwyd: (2021)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
gan: Jun Zhang, et al.
Cyhoeddwyd: (2022)

Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease
gan: Zheng Xu, et al.
Cyhoeddwyd: (2022)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
gan: Yang Ye, et al.
Cyhoeddwyd: (2022)

Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
gan: Yuanyuan Zhong, et al.
Cyhoeddwyd: (2022)

A Chinese herbal decoction, Jian-Pi-Yi-Shen, regulates the expressions of erythropoietin and pro-inflammatory cytokines in cultured cells
gan: Jianping Chen, et al.
Cyhoeddwyd: (2018)

Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
gan: Huihui Xu, et al.
Cyhoeddwyd: (2022)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
gan: Congyang Ding, et al.
Cyhoeddwyd: (2022)

Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
gan: Zhongwei Sha, et al.
Cyhoeddwyd: (2023)

Study on the Anti-demyelination Mechanism of Bu-Shen-Yi-Sui Capsule in the Central Nervous System Based on Network Pharmacology and Experimental Verification
gan: Zheng Zha, et al.
Cyhoeddwyd: (2022)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions
gan: Chen JR, et al.
Cyhoeddwyd: (2015)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
gan: Jun Zhang, et al.
Cyhoeddwyd: (2022)

Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders
gan: Ang Jia, et al.
Cyhoeddwyd: (2023)

Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach
gan: Zhong Y, et al.
Cyhoeddwyd: (2023)

Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer's disease by the analysis of the feasible signaling pathway of network pharmacology
gan: Yingchao Hu, et al.
Cyhoeddwyd: (2024)

Dysbiosis of the intestinal microbiota and type 2 diabetes mellitus, modern correction strategies: A review
gan: Regina A. Isaeva, et al.
Cyhoeddwyd: (2024)

Dysbiosis of gut microbiota and human diseases
gan: Sangeeta Huidrom, et al.
Cyhoeddwyd: (2020)

Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis
gan: Ling Fang, et al.
Cyhoeddwyd: (2017)

JianPiYiShen formula prevents cisplatin-induced acute kidney injury in mice by improving necroptosis through MAPK pathway
gan: Zhongtang Li, et al.
Cyhoeddwyd: (2024)

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction
gan: Zhichao Liu, et al.
Cyhoeddwyd: (2024)

The Effectiveness and Safety of Yi Shen Juan Bi Pill on Rheumatoid Arthritis: a Protocol for Systematic Review and/or Meta-Analysis
gan: Gyoungeun Park, et al.
Cyhoeddwyd: (2024)

Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model
gan: Huicun Zhang, et al.
Cyhoeddwyd: (2021)

Gut microbiota dysbiosis in rheumatoid arthritis: a systematic review and meta-analysis
gan: Qin-Yi Su, et al.
Cyhoeddwyd: (2024)